Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (131-140 of 285) with videos related to

Pageof 29
Sort By:
Annals of Surgical Oncology|March 30, 2002
An experimental evaluation of three preoperative radiation regimens for resectable rectal cancerGenc Basha, Willy Landuyt, Jack Fowler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
ESTRO ACROP guidelines for target volume definition in pancreatic cancerThomas B Brunner, Karin Haustermans, Florence Huguet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomicsPhilippe Bulens, Alice Couwenberg, Martijn Intven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2006
Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1Harlinde De Schutter, Barbara Barbé, Marijke Spaepen, et al.
Radiation Oncology (London, England)|September 24, 2008
A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinomaTom Budiharto, Karin Haustermans, Eric Van Cutsem, et al.
Clinical Colorectal Cancer|January 10, 2025
Organ Preservation After Immune Checkpoint Inhibition for Locally Advanced Rectal CancerCharlotte Claeys, Antoon Billiet, Karin Haustermans, et al.
Cancers|September 27, 2025
Radiotherapy for Locally Advanced Pancreatic Cancer in the Modern Era: A Systematic Review and Meta-AnalysisSun Hyun Bae, Won Il Jang, Jeong Il Yu, et al.
BMC Cancer|September 8, 2017
Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancerAnnelies Gonnissen, Sofie Isebaert, Christiaan Perneel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2017
Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancerInes Joye, Annelies Debucquoy, Christophe M Deroose, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2018
Prospective data registration and clinical trials for particle therapy in EuropeJohannes A Langendijk, Roberto Orecchia, Karin Haustermans, et al.
Pageof 29

Showing results (131-140 of 285) with videos related to

Sort By:
Pageof 29
Annals of Surgical Oncology|March 30, 2002
An experimental evaluation of three preoperative radiation regimens for resectable rectal cancerGenc Basha, Willy Landuyt, Jack Fowler, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 31, 2020
ESTRO ACROP guidelines for target volume definition in pancreatic cancerThomas B Brunner, Karin Haustermans, Florence Huguet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
Predicting the tumor response to chemoradiotherapy for rectal cancer: Model development and external validation using MRI radiomicsPhilippe Bulens, Alice Couwenberg, Martijn Intven, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2006
Microsatellite alterations in head and neck squamous cell carcinoma and relation to expression of pimonidazole, CA IX and GLUT-1Harlinde De Schutter, Barbara Barbé, Marijke Spaepen, et al.
Radiation Oncology (London, England)|September 24, 2008
A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinomaTom Budiharto, Karin Haustermans, Eric Van Cutsem, et al.
Clinical Colorectal Cancer|January 10, 2025
Organ Preservation After Immune Checkpoint Inhibition for Locally Advanced Rectal CancerCharlotte Claeys, Antoon Billiet, Karin Haustermans, et al.
Cancers|September 27, 2025
Radiotherapy for Locally Advanced Pancreatic Cancer in the Modern Era: A Systematic Review and Meta-AnalysisSun Hyun Bae, Won Il Jang, Jeong Il Yu, et al.
BMC Cancer|September 8, 2017
Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancerAnnelies Gonnissen, Sofie Isebaert, Christiaan Perneel, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2017
Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancerInes Joye, Annelies Debucquoy, Christophe M Deroose, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2018
Prospective data registration and clinical trials for particle therapy in EuropeJohannes A Langendijk, Roberto Orecchia, Karin Haustermans, et al.
Pageof 29